Palatin Technologies
PTN
#10552
Rank
NZ$32.42 M
Marketcap
NZ$18.23
Share price
1.45%
Change (1 day)
12,134.69%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -NZ$8.39 Million

According to Palatin Technologies's latest financial reports the company's current earnings are NZ$8.84 Million. In 2024 the company made an earning of -NZ$46.81 Million, an increase over its 2023 earnings that were of -NZ$56.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$8.39 Million-82.08%
2024 -NZ$46.81 Million-16.9%
2023 -NZ$56.33 Million5.99%
2022 -NZ$53.14 Million-13.7%
2021 -NZ$61.58 Million33.25%
2020 -NZ$46.21 Million-172.11%
2019 NZ$64.08 M2352.33%
2018 NZ$2.61 M-94.13%
2017 NZ$44.52 M-154.92%
2016 -NZ$81.07 Million3.67%
2015 -NZ$78.21 Million878%
2014 -NZ$8 Million-72.64%
2013 -NZ$29.23 Million-33.11%
2012 -NZ$43.7 Million77.71%
2011 -NZ$24.59 Million
2003 -NZ$41.64 Million29.93%
2002 -NZ$32.05 Million36.18%
2001 -NZ$23.53 Million
1999 -NZ$19.53 Million6.04%
1998 -NZ$18.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.13 B-541,884.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$25.47 B-305,913.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
NZ$1.38 B-16,758.74%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-NZ$20.86 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.28 B-3,513.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.21 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$0.16 B-2,097.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-NZ$51.23 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-NZ$0.11 Billion 1,108.36%๐Ÿ‡บ๐Ÿ‡ธ USA